-transparent.png){kind=logo}
The reliability of serum MM3/MM1 ratio as a marker for AMI was evaluated in 81 consecutive coronary-care admission. Of these, 62 patients were diagnosed as definite infarction and 19 patients as angina, using WHO criteria. The MM3/MM1 ratio in the admission serum sample was 1.85 +/- 2.01 in 62 patients with definite infarction; in contrast, the MM3/MM1 ratio was 0.24 +/- 0.14 in 19 patients with angina (P less than 0.01 for MI group vs angina group). Among the AMI patients admitted within 12 h after onset, the diagnostic accuracy of the ratio MM3/MM1 was higher than CK, CK-MB, LDH, LD1/LD2 and GOT and similar to Mb in the initial serum samples. It seems that the MM3/MM1 ratio was a better enzyme marker than the others in the early stage of AMI, especially before 12 h.
Q Meng, and
X Yang
November 1996,
Harefuah,
Q Meng, and
X Yang
September 1994,
Clinica chimica acta; international journal of clinical chemistry,
Q Meng, and
X Yang
January 1989,
Electrophoresis,
Q Meng, and
X Yang
April 1989,
Clinical biochemistry,
Q Meng, and
X Yang
February 1986,
Clinica chimica acta; international journal of clinical chemistry,
Q Meng, and
X Yang
January 1990,
Clinical chemistry,
Q Meng, and
X Yang
June 1983,
Circulation,
Q Meng, and
X Yang
March 1985,
Clinical chemistry,
Q Meng, and
X Yang
December 1991,
Clinical science (London, England : 1979),
Q Meng, and
X Yang
November 1987,
Clinical chemistry,
